# Pinta Biotherapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pinta-biotherapeutics

- Industry: Biotechnology
- Headquarters: Brisbane, US
- Total disclosed funding: $18M
- Latest round: Series B (Dec 3, 2013)
- Investors on record: 7

## About

Based in California, US, Pinta Biotherapeutics provides bio-therapies that reverse protein energy wasting in kidney disease.

## Funding rounds

- Series B, Dec 3, 2013, $18M — Domain Associates, Kleiner Perkins, DAG Ventures, Amgen Inc., EcoR1 Capital, Bristol-Myers Squibb Company, Alexandria Real Estate Equities

## Investors

- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series B
- Kleiner Perkins (https://capitalatlas.ai/funds/kleiner-perkins) — Series B
- DAG Ventures (https://capitalatlas.ai/funds/dag-ventures) — Series B
- Amgen Inc. — Series B
- EcoR1 Capital (https://capitalatlas.ai/funds/ecor1-capital) — Series B
- Bristol-Myers Squibb Company — Series B
- Alexandria Real Estate Equities — Series B